Sichuan Hebang (China) Today

603077 Stock   2.01  0.09  4.29%   

Performance

11 of 100

 
Weak
 
Strong
Good

Odds Of Distress

Less than 10

 
High
 
Low
Low
Sichuan Hebang is trading at 2.01 as of the 22nd of November 2024, a 4.29 percent decrease since the beginning of the trading day. The stock's open price was 2.1. Sichuan Hebang has less than a 10 % chance of experiencing some financial distress in the next two years of operation and had a good performance during the last 90 days. Equity ratings for Sichuan Hebang Biotechnology are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 2nd of April 2023 and ending today, the 22nd of November 2024. Click here to learn more.
Business Domain
Materials
IPO Date
31st of July 2012
Category
Basic Materials
Sichuan Hebang is entity of China. It is traded as Stock on SHG exchange. The company has 8.83 B outstanding shares. More on Sichuan Hebang Biotechnology

Moving together with Sichuan Stock

  0.64601899 Zijin Mining GroupPairCorr
  0.77600309 Wanhua Chemical GroupPairCorr
  0.91600019 Baoshan Iron SteelPairCorr
  0.92002493 Rongsheng PetrochemicalPairCorr
  0.91600010 Inner Mongolia BaoTouPairCorr

Sichuan Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Sichuan Hebang's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Sichuan Hebang or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Chairman GMXiaoping Zeng
Thematic IdeaBiotech (View all Themes)
Business ConcentrationCommodity Chemicals, Materials, Basic Materials, Biotech, Materials, Chemicals, Materials, Basic Materials (View all Sectors)
Sichuan Hebang's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Sichuan Hebang's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Debt Levels
Sichuan Hebang can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Sichuan Hebang's financial leverage. It provides some insight into what part of Sichuan Hebang's total assets is financed by creditors.
Liquidity
Sichuan Hebang cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. Sichuan Hebang Biotechnology has accumulated 1.17 B in total debt. Debt can assist Sichuan Hebang until it has trouble settling it off, either with new capital or with free cash flow. So, Sichuan Hebang's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Sichuan Hebang Biote sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Sichuan to invest in growth at high rates of return. When we think about Sichuan Hebang's use of debt, we should always consider it together with cash and equity.

Other Cashflows From Financing Activities

718.69 Million
Sichuan Hebang Biotechnology (603077) is traded on Shanghai Stock Exchange in China and employs 7,169 people. Sichuan Hebang is listed under Commodity Chemicals category by Fama And French industry classification. The company currently falls under 'Large-Cap' category with a current market capitalization of 17.93 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Sichuan Hebang's market, we take the total number of its shares issued and multiply it by Sichuan Hebang's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Sichuan Hebang Biote operates under Chemicals sector and is part of Materials industry. The entity has 8.83 B outstanding shares. Sichuan Hebang generates positive cash flow from operations, but has no cash available
Check Sichuan Hebang Probability Of Bankruptcy
Ownership Allocation
Sichuan Hebang Biote shows a total of 8.83 Billion outstanding shares. Sichuan Hebang Biote maintains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Sichuan Ownership Details

Sichuan Hebang Biote Risk Profiles

Although Sichuan Hebang's alpha and beta are two of the key measurements used to evaluate Sichuan Hebang's performance over the market, the standard measures of volatility play an important role as well.

Sichuan Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Sichuan Hebang without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Suggestion Now

   

Portfolio Suggestion

Get suggestions outside of your existing asset allocation including your own model portfolios
All  Next Launch Module

Sichuan Hebang Corporate Management

Elected by the shareholders, the Sichuan Hebang's board of directors comprises two types of representatives: Sichuan Hebang inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Sichuan. The board's role is to monitor Sichuan Hebang's management team and ensure that shareholders' interests are well served. Sichuan Hebang's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Sichuan Hebang's outside directors are responsible for providing unbiased perspectives on the board's policies.
Anping LiuDeputy ManagerProfile
Liu AnpingDeputy MangProfile
Siying JiangSecretary BoardProfile
Huirong YangGeneral ManagerProfile

Other Information on Investing in Sichuan Stock

Sichuan Hebang financial ratios help investors to determine whether Sichuan Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Sichuan with respect to the benefits of owning Sichuan Hebang security.